907972-23-0 Usage
Uses
Used in Pharmaceutical Industry:
1-Cyclopropyl-piperazin-2-one serves as a crucial building block for the development of various pharmaceuticals. Its unique structure and reactivity contribute to its value in drug discovery and development, allowing for the creation of a diverse range of medicinal compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 1-Cyclopropyl-piperazin-2-one is utilized as a key intermediate in the synthesis of a variety of agrochemicals. Its role in this industry is pivotal for the development of new compounds aimed at enhancing crop protection and improving agricultural productivity.
Used in Organic Chemistry:
1-Cyclopropyl-piperazin-2-one's distinctive structure also makes it a valuable starting material in organic chemistry. It is employed in the preparation of a wide array of organic compounds, showcasing its versatility and importance in the synthesis of complex molecules for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 907972-23-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,7,9,7 and 2 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 907972-23:
(8*9)+(7*0)+(6*7)+(5*9)+(4*7)+(3*2)+(2*2)+(1*3)=200
200 % 10 = 0
So 907972-23-0 is a valid CAS Registry Number.
907972-23-0Relevant articles and documents
PYRIMIDO[5,4-d]PYRIMIDINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS
-
Page/Page column 134; 175-176, (2021/09/04)
The present invention relates to pyrimido[5,4-d]pyrimidine derivatives of formula (I), including pharmaceutically acceptable salts and solvates thereof. Compounds of the invention are inhibitors of ENT family transporter, especially of ENT1, and are useful as therapeutic compounds for the treatment of cancers. The invention also relates to the combined use of the pyrimido[5,4-d]pyrimidine derivatives with an adenosine receptor antagonist, for the treatment of cancers.
PIPERAZINYL ANTIVIRAL AGENTS
-
Page/Page column 159, (2011/04/25)
Provided are compounds of Formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).
